Cosmos Health Inc. (COSM) earnings

COSM earnings moved a median of -0.99% by the close. Quarterly and annual COSM reports and results, each read against the price at its own news timestamp. Back to the COSM overview →

30 measured COSM earnings events.

Where these COSM earnings landedvs 30 measured COSM earnings reactions
COSM earningsMiddle 50% · -4.35% to +4.10%Zero: 0.00%Median: -0.99%Median -0.99%-6.00%0+6.00%
Middle 50% of COSM earnings reactions-4.35% to +4.10%
Median reaction (to close)-0.99%
Measured reactions30
Point-in-time · zero look-ahead

Half of the 30 COSM earnings events with a measured close landed between -4.35% and +4.10%; 33% closed up.

DateHeadlineEvent5-minTo close
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 MillionPress release+3.37%+1.87%
Form 10-Q Cosmos Health Inc. For: Jun 30SEC filing · Form 10-Q-5.08%-1.03%
Form NT 10-Q Cosmos Health Inc. For: Jun 30SEC filing · Form NT-0.95%-6.82%
CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility CapacityPress release+4.05%+9.83%
Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion UnderwayPress release-3.49%-7.13%
Form 10-Q Cosmos Health Inc. For: Mar 31SEC filing · Form 10-Q-3.49%-7.13%
Form NT 10-Q Cosmos Health Inc. For: Mar 31SEC filing · Form NT+1.27%-2.10%
Form 10-K Cosmos Health Inc. For: Dec 31SEC filing · Form 10-K+1.32%+6.84%
Form NT 10-K Cosmos Health Inc. For: Dec 31SEC filing · Form NT-0.31%-0.28%
Form 10-Q Cosmos Health Inc. For: Sep 30SEC filing · Form 10-Q+0.00%-4.11%
Form 10-Q Cosmos Health Inc. For: Jun 30SEC filing · Form 10-Q+0.52%-5.40%
Form NT 10-Q Cosmos Health Inc. For: Jun 30SEC filing · Form NT+3.46%+5.33%
Form 10-Q Cosmos Health Inc. For: Mar 31SEC filing · Form 10-Q+5.14%+6.19%
Form 10-K Cosmos Health Inc. For: Dec 31SEC filing · Form 10-K-1.66%-3.33%
Form NT 10-K Cosmos Health Inc. For: Dec 31SEC filing · Form NT—-0.77%
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M QoQPress release-0.49%-3.08%
Form 10-Q Cosmos Health Inc. For: Sep 30SEC filing · Form 10-Q+0.00%-1.58%
Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross ProfitPress release-6.67%-10.83%
Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023Press release+0.94%+0.00%
Form 10-Q Cosmos Health Inc. For: Jun 30SEC filing · Form 10-Q-6.67%-10.83%
Form 10-Q Cosmos Health Inc. For: Mar 31SEC filing · Form 10-Q+1.60%+0.80%
Form NT 10-Q Cosmos Health Inc. For: Jun 30SEC filing · Form NT-2.64%-4.42%
Form 10-K Cosmos Health Inc. For: Dec 31SEC filing · Form 10-K-1.42%+8.49%
Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-QPress release+0.00%+7.25%
Form NT 10-Q Cosmos Health Inc. For: Mar 31SEC filing · Form NT+0.00%-5.21%
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-KPress release+3.33%+4.85%
Form NT 10-K Cosmos Health Inc. For: Dec 31SEC filing · Form NT-0.01%-2.11%
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/SharePress release+3.85%-0.96%
Form 10-Q Cosmos Health Inc. For: Sep 30SEC filing · Form 10-Q+3.85%-0.96%
Form NT 10-Q Cosmos Health Inc. For: Sep 30SEC filing · Form NT-0.07%+5.77%
That’s how COSM usually reacts to earnings — get an email when it moves on news →
Keep exploring

More COSM: analyst actions → · SEC filings → · COSM overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
TERRASCENT CORP (TRSSF)453-0.04%44%
Glaukos Corporation (GKOS)452+0.04%51%
ROCHE HOLDING LTD S/ADR (RHHBY)449+0.03%52%
CareDx, Inc. (CDNA)443-0.11%47%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.